The evidence-based deworming protocol for dogs is stratified by lifestyle-based risk category, with the highest-risk dogs — those with outdoor access, contact with other animals, prey exposure, or contact with children and elderly people — requiring the most frequent treatment. The European Scientific Counsel Companion Animal Parasites (ESCCAP) guidelines form the framework for this risk stratification. Parasites and V…
Risk categorization drives frequency. Dogs are assigned to risk categories based on lifestyle factors including outdoor access, contact with other dogs, hunting or prey consumption, ingestion of slugs or snails, and contact with vulnerable human populations such as children and the elderly. Parasites and V… The majority of dogs in surveyed populations fall into the highest-risk category — 89% of dogs in one national survey were classified as highest risk (category D) based on these criteria. Parasites and V…
Compliance with recommended deworming frequency is the primary clinical gap. Despite most dogs qualifying for the highest-risk deworming schedule, actual compliance with recommended protocols is poor — recorded at 6% for highest-risk dogs in France. Parasites and V… This gap represents a meaningful zoonotic risk, as most high-risk dogs have contact with children or elderly individuals. Parasites and V…
Ectoparasite and tick-borne disease risk follows a parallel geographic and lifestyle framework. The Companion Animal Parasite Council recommends year-round broad-spectrum flea and tick control for all dogs, with annual testing for tick-borne pathogens. AAHA Clinical G… Tick-borne disease risk has increased substantially across North America, with canine infection rates rising 41–167% based on national antibody prevalence surveys. AAHA Clinical G…
Core vaccination (canine distemper virus, canine adenovirus 2, canine parvovirus 2, and rabies in endemic regions) is required for every dog regardless of lifestyle or geography. Non-core vaccines — including Leptospira and Bordetella bronchiseptica with or without canine parainfluenza virus — are indicated based on geographic location and individual lifestyle risk. WSAVA Global Gu…
| Risk Factor | Category | Recommended Action | Key Caveat |
|---|---|---|---|
| Outdoor access, prey contact, contact with children/elderly | Highest risk (D) | Most frequent deworming per ESCCAP schedule | Compliance recorded at only 6% Parasites and V… |
| All dogs, all geographies | Universal | Year-round flea/tick control; annual tick-borne disease testing AAHA Clinical G… | Risk not uniform across regions — local prevalence knowledge required AAHA Clinical G… |
| Geographic tick-borne disease exposure | Variable | Tick control products; annual serology AAHA Clinical G… | Canine infection rates up 41–167% across North America AAHA Clinical G… |
| Endemic rabies region; lifestyle exposure | Core + noncore | CDV/CAV2/CPV2/rabies core; Leptospira/CIRDC noncore WSAVA Global Gu… | Noncore vaccines not indicated without evidence of local disease or exposure risk WSAVA Global Gu… |
The veterinary literature does not provide specific deworming drug names, doses, or treatment intervals within the provided sources — the ESCCAP frequency recommendations by category are referenced but not reproduced here.
Would you like guidance on which specific anthelmintic agents and dosing intervals are recommended for each ESCCAP risk category?